All articles by Manish Kumar

Manish Kumar

QHSLab and South Dakota State University celebrate NSF invitation to submit STTR application for AIR-GUIDDE technology

This exclusive invitation, under the NSF Small Business Technology Transfer (STTR) program, underscores the transformative potential of AIR-GUIDDE and highlights the significant merits of the project, even at this early stage

Philips expands deal with Sim&Cure to boost neurovascular solutions

The collaboration will integrate Sim&Size software into Azurion to strengthen Philips’ position in interventional neuro solutions and enhance image-guided therapy capabilities

Centinel Spine reports long-term positive results of prodisc L system

The study validates prodisc L’s fixed-core design, showing low revision and adjacent-level surgery rates, with equivalent outcomes for 1- and 2-level LTDR, and prior surgery patients

LuminoDx announces CLIA certification for San Diego laboratory

CLIA certification, issued by the Centers for Medicare and Medicaid Services (CMS), is required for clinical laboratories to accept and test human samples for diagnostic purposes

Capstan Medical raises $110m in Series C for heart valve solutions

The heart valve intervention provider will use the new funding to advance its structural heart treatments and accelerate clinical and development efforts for upcoming trials

Mindset Medical gets FDA clearance for contactless pulse rate IVC app

The IVC App allows the remote collection of pulse rate measurements using patients’ own devices, offering easy access to health data at home, in offices, or healthcare settings

Osteotec appointed as exclusive distributor for Cerapedics in the UK and Ireland

This agreement expands Osteotec’s extensive offering, providing healthcare professionals with access to Cerapedics’ i-FACTOR Bone Graft Putty and i-FACTOR Bone Graft FLEX FR products for use in spine procedures

FemPulse receives FDA IDE approval for the pivotal clinical trial of its wearable bioelectronic device for overactive bladder in women

FemPulse Corporation is a bioelectronic medicine company developing a novel wearable bioelectronic platform for the personalized treatment of medical conditions in women

Agilent wins IVDR certification for PD-L1 IHC 28-8 pharmDx assay

PD-L1 IHC 28-8 pharmDx provides key insights into PD-L1 expression, aiding in predicting response to anti-PD-1 therapies like Opdivo and Opdualag across various cancer types